{"id":5759,"date":"2026-01-30T18:06:05","date_gmt":"2026-01-30T17:06:05","guid":{"rendered":"https:\/\/heva-data.com\/publication\/real-world-study-on-tebentafusp-use-in-metastatic-uveal-melanoma-in-france-interim-analysis-of-the-primum-0-study\/"},"modified":"2026-03-16T10:31:19","modified_gmt":"2026-03-16T09:31:19","slug":"real-world-study-on-tebentafusp-use-in-metastatic-uveal-melanoma-in-france-interim-analysis-of-the-primum-0-study","status":"publish","type":"publication","link":"https:\/\/heva-data.com\/en\/publication\/real-world-study-on-tebentafusp-use-in-metastatic-uveal-melanoma-in-france-interim-analysis-of-the-primum-0-study\/","title":{"rendered":"Real-world study on tebentafusp use in metastatic uveal melanoma in France: interim analysis of the PRIMUM.0 study"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_crdt_document":"","advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false},"categories":[5],"class_list":["post-5759","publication","type-publication","status-publish","hentry","category-publication"],"_links":{"self":[{"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/publication\/5759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/media?parent=5759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heva-data.com\/en\/wp-json\/wp\/v2\/categories?post=5759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}